373 related articles for article (PubMed ID: 4714324)
21. [Hormone therapy and chemotherapy of metastasizing breast cancer. Experiences of the Basle Oncology Center, 1969-72].
Byland W; Nagel G; Senn HJ
Schweiz Med Wochenschr; 1974 Aug; 104(31):1077-85. PubMed ID: 4445838
[No Abstract] [Full Text] [Related]
22. Activity of adriamycin in metastatic breast cancer resistant to a combination regimen with cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, and prdnisone.
Frederiksen PL; Joergensen ST; Roesdahl K; Thomsen J; Mouridsen HT
Cancer Treat Rep; 1978 Mar; 62(3):449-50. PubMed ID: 348314
[No Abstract] [Full Text] [Related]
23. [Preliminary experiences in the treatment of metastatic mamma carcinoma by polychemotherapy-according to Cooper (author's transl)].
Barndt J
Radiobiol Radiother (Berl); 1976; 17(3):355-63. PubMed ID: 981540
[No Abstract] [Full Text] [Related]
24. [Chemotherapy of metastasizing breast cancers. Indications and results].
Gallmeier WM; Bruntsch U; Schmidt CG
Dtsch Med Wochenschr; 1975 Jan; 100(2):35-41. PubMed ID: 1112210
[TBL] [Abstract][Full Text] [Related]
25. [Cooper's combination chemotherapy of metastasizing breast carcinoms].
van Kaick G; Drings P; Fritsch H; Moskwa G
Verh Dtsch Ges Inn Med; 1973; 79():1371-3. PubMed ID: 4790187
[No Abstract] [Full Text] [Related]
26. Sequential continuous infusion with doxorubicin and vinblastine: an effective chemotherapy combination for patients with advanced breast cancer previously treated with cyclophosphamide, methotrexate, 5-FU, vincristine, and prednisone.
Tannir N; Yap HY; Hortobagyi GH; Hug V; Buzdar AU; Blumenschein GR
Cancer Treat Rep; 1984; 68(7-8):1039-41. PubMed ID: 6547638
[TBL] [Abstract][Full Text] [Related]
27. Combination chemotherapy in advanced breast cancer.: a randomized trial comparing a three-vs a five-drug program.
Muss HB; White DR; Cooper MR; Richards F; Spurr CL
Arch Intern Med; 1977 Dec; 137(12):1711-4. PubMed ID: 337916
[TBL] [Abstract][Full Text] [Related]
28. Alternating versus sequential therapy in advanced breast cancer.
Romero A; Rabinovich MG; Pérez JE; Macchiavelli M; Leone BA; Strauss E; Goldar D; Alvarez LA; Vallejo C
Medicina (B Aires); 1987; 47(3):243-8. PubMed ID: 3326994
[No Abstract] [Full Text] [Related]
29. Treatment of hepatic metastases from breast cancer.
Bugarski M; Vuletić L; Boberić J; Milosavljević A; Dilparić S; Tomin R; Naumović P
Clin Oncol; 1978 Jun; 4(2):167-71. PubMed ID: 668248
[No Abstract] [Full Text] [Related]
30. Chemotherapy of breast cancer.
Mitchell MS
Conn Med; 1975 Jan; 39(1):4-5. PubMed ID: 1109851
[No Abstract] [Full Text] [Related]
31. [Results of high-dosage attack treatment with cytostatics in mammary and ovarian cancer (author's transl)].
Möhlen KH; Beller FK
Strahlentherapie; 1978 Sep; 154(9):622-6. PubMed ID: 684782
[TBL] [Abstract][Full Text] [Related]
32. [Cytostatic treatment of metastasizing breast cancer. A prospective controlled comparison between single drug and multiple drug chemotherapy].
Mouridsen HT; Palshof T; Brahm M; Rahbek I
Ugeskr Laeger; 1977 Oct; 139(44):2632-5. PubMed ID: 929742
[No Abstract] [Full Text] [Related]
33. Natural history of more than 20 years of node-positive primary breast carcinoma treated with cyclophosphamide, methotrexate, and fluorouracil-based adjuvant chemotherapy: a study by the Cancer and Leukemia Group B.
Weiss RB; Woolf SH; Demakos E; Holland JF; Berry DA; Falkson G; Cirrincione CT; Robbins A; Bothun S; Henderson IC; Norton L;
J Clin Oncol; 2003 May; 21(9):1825-35. PubMed ID: 12721260
[TBL] [Abstract][Full Text] [Related]
34. Five-drug therapy in advanced breast cancer: factors influencing toxicity and response.
Davis HL; Ramirez G; Ellerby RA; Ansfield FJ
Cancer; 1974 Aug; 34(2):239-45. PubMed ID: 4852055
[No Abstract] [Full Text] [Related]
35. Multiple drug intensification after cyclophosphamide, doxorubicin, and 5-fluorouracil (CAF) induction in metastatic breast cancer: a Southeastern Cancer Study Group phase II trial.
Vogel CL; Raney M; Carpenter J
Cancer Treat Rep; 1987 Dec; 71(12):1271-3. PubMed ID: 3690536
[No Abstract] [Full Text] [Related]
36. [Association of VCR-5FU-CYCLO-PDN in the treatment of disseminated carcinoma of the breast (author's transl)].
Estapé J; Millá A; Prats M; Herranz M; Visa J
Med Clin (Barc); 1979 Aug; 73(4):136-9. PubMed ID: 481010
[TBL] [Abstract][Full Text] [Related]
37. Chemotherapy for breast cancer.
Allegra JC; Lippman ME
Compr Ther; 1979 Feb; 5(2):13-7. PubMed ID: 428200
[TBL] [Abstract][Full Text] [Related]
38. Adverse effect of radiotherapy on adjuvant chemotherapy for carcinoma of the breast.
Holland JF; Glidewell O; Cooper RG
Surg Gynecol Obstet; 1980 Jun; 150(6):817-21. PubMed ID: 7376042
[TBL] [Abstract][Full Text] [Related]
39. Cyclic combination chemotherapy for metastatic breast cancer.
Biran S; Krasnokuki D; Hochman A; Brufman G
Isr J Med Sci; 1977 Jun; 13(6):582-6. PubMed ID: 885710
[TBL] [Abstract][Full Text] [Related]
40. [Results of "5-drug" treatment of advanced breast cancer].
Dorociak R
Pol Tyg Lek; 1981 Sep; 36(38):1467-70. PubMed ID: 7329862
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
